A detailed history of Black Rock Inc. transactions in Beyond Air, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 518,985 shares of XAIR stock, worth $295,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares
518,985
Previous 1,807,215 71.28%
Holding current value
$295,821
Previous $3.14 Million 91.09%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.54 - $1.67 $695,644 - $2.15 Million
-1,288,230 Reduced 71.28%
518,985 $280,000
Q1 2024

May 10, 2024

SELL
$1.3 - $2.15 $65,609 - $108,508
-50,469 Reduced 2.72%
1,807,215 $3.14 Million
Q4 2023

Feb 13, 2024

BUY
$1.4 - $2.46 $140,226 - $246,398
100,162 Added 5.7%
1,857,684 $3.64 Million
Q3 2023

Nov 13, 2023

BUY
$2.31 - $4.18 $67,248 - $121,688
29,112 Added 1.68%
1,757,522 $4.06 Million
Q2 2023

Aug 11, 2023

BUY
$4.26 - $6.92 $6.13 Million - $9.96 Million
1,439,168 Added 497.57%
1,728,410 $7.36 Million
Q1 2023

May 12, 2023

BUY
$5.65 - $7.56 $12,181 - $16,299
2,156 Added 0.75%
289,242 $1.95 Million
Q4 2022

Feb 13, 2023

BUY
$5.47 - $7.9 $5,240 - $7,568
958 Added 0.33%
287,086 $1.86 Million
Q3 2022

Nov 14, 2022

BUY
$7.42 - $11.39 $147,880 - $227,002
19,930 Added 7.49%
286,128 $2.13 Million
Q2 2022

Aug 12, 2022

BUY
$4.96 - $7.83 $6,438 - $10,163
1,298 Added 0.49%
266,198 $1.78 Million
Q1 2022

May 12, 2022

BUY
$6.33 - $9.53 $107,407 - $161,705
16,968 Added 6.84%
264,900 $1.77 Million
Q4 2021

Feb 10, 2022

BUY
$8.44 - $15.61 $1.26 Million - $2.33 Million
149,393 Added 151.61%
247,932 $2.34 Million
Q3 2021

Nov 09, 2021

BUY
$5.9 - $12.54 $248,106 - $527,332
42,052 Added 74.45%
98,539 $1.1 Million
Q2 2021

Aug 11, 2021

BUY
$4.72 - $7.15 $266,618 - $403,882
56,487 New
56,487 $366,000

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $17M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.